Alexis Victoria Bonsall LPCA, NCC

Recommended Articles

• Josh Duggar

  Who is Josh Duggar?Josh Duggar is best known for the reality show “19 Kids and Counting”, which is a show that follows the everyday life of the Duggar family. Aside from being a television personality, he is also a political activist. He used to be a used car salesman and later became an...

• Vitamins for Celiac Disease

  A gluten-free diet is beneficial for those diagnosed with celiac disease. However, to avoid gluten from the diet, they need to be aware of what they are eating. Gluten-free products tend to be deficient in certain vitamins and minerals, which are essential for our body. Moreover, in some cases, the...

• Bone Marrow Biopsies Might Not Be Necessary for Follicular Lymphoma Patients

  Those suffering from follicular lymphoma have become accustomed to bone marrow biopsies throughout their treatment so that doctors can monitor their responses. However, a new study has shown these processes may not be as integral as former mandates have implied. The study has recently been published...

• What’s Getting in the Way of Treatment for Rare Types of Ovarian Cancer?

  Women who present to their healthcare provider with acute symptoms often already have progressed ovarian cancer. It is difficult to make medical advances with rare ovarian cancers because there are even fewer patients. Additionally, by the time patients begin to receive treatment, the cancer is...

• What Are The Signs and Symptoms of HIV?

  HIV infection is an infection that is caused by the HIV virus. The virus infects and destroys the CD4+ cells in the human body hence weakening the immune system. It is transmitted from one person to another through exchange of fluids. These fluids may involve semen, vaginal fluids, blood or breast...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...